Offered by: Nemours Children's Health, Jacksonville
Location: Jacksonville, Fla.
SCUSF 0901 Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor
To compare the effects of Modafinil given to children with neurocognitive changes following treatment for brain cancer.
Age ≥6 years and ≤17 years 10 months at the time of study entry.
Length of study is 10 weeks. Includes neurocognitive tests and physical exam.
Trial Name: SCUSF 0901 Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor
IRB# 285283
(800) 354-5690 Email UsLearn more about clinical trials and get answers to questions you might have.
Go to FAQs View All Clinical TrialsNemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.